comparemela.com

Latest Breaking News On - Akkadian partner - Page 4 : comparemela.com

Stock Market | FinancialContent Business Page

Stock Market | FinancialContent Business Page
financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.

ERYTECH announces that the Commercial Court has rejected Akkadian s request to postpone the vote on the merger with Pherecydes Pharma

ERYTECH announces that the Commercial Court has rejected Akkadian s request to postpone the vote on the merger with Pherecydes Pharma
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

ERYTECH announces that the Commercial Court has rejected Akkadian s request to postpone the vote on the merger with Pherecydes Pharma

ERYTECH announces that the Commercial Court has rejected Akkadian s request to postpone the vote on the merger with Pherecydes Pharma
finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.

Erytech s Battle With Activist Investor Echoes As Pherecydes Pharma Merger Vote Comes Closer

In February, Erytech Pharma SA (NASDAQ: ERYP) announced its proposed combination with Pherecydes Pharma S.A. In June, Erytech announced that Akkadian initiated proceedings to postpone the vote, scheduled on 23 June, on the merger with Pherecydes. The merger would see Pherecydes absorbed into publicly listed Erytech, with Pherecydes shareholders receiving 15 new Erytech shares for every four of their current shares. Monday, Erytech Pharma responded to what it described as Akkadian Partners' "disi

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.